hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06275022, orgStudyIdInfo id: NanjingCH011665, briefTitle: A Prospective Study on the Treatment of cLM Based on ICG Imaging, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-01-01, primaryCompletionDateStruct date: 2025-12-31, completionDateStruct date: 2026-06-30, studyFirstPostDateStruct date: 2024-02-23, lastUpdatePostDateStruct date: 2024-02-23, sponsorCollaboratorsModule leadSponsor name: Nanjing Children's Hospital, class: OTHER, descriptionModule briefSummary: The goal of this prospective randomized controlled study is to explore the role of indocyanine green-fluorescence imaging in management of cystic lymphatic malformation.. To clarify the application value of indocyanine green-fluorescence imaging in both diagnosis and treatment of cystic lymphatic malformation (cLM) in children, is helpful for exploring pathogenesis of cLM, and providing a clearer scientific basis for subsequent surgical intervention. It also provides alternative for the future diagnosis and treatment of cLM.Participants will receive indocyanine green-fluorescence imaging before operation, while the patients in control group will receive traditional operation.Researchers will compare difference in curative effect between two groups., conditionsModule conditions: Lymphatic Malformation, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 110, type: ESTIMATED, armsInterventionsModule interventions name: Inflow occlusion with perforation of septation and sclerotherapy, interventions name: Perforation of septation and sclerotherapy, interventions name: Indocyanine green-guided partial resection and sclerotherapy, interventions name: Partial resection and sclerotherapy, outcomesModule primaryOutcomes measure: Cure rate, primaryOutcomes measure: Effective rate, primaryOutcomes measure: Treatment frequency, secondaryOutcomes measure: Likert score, secondaryOutcomes measure: Wound infection, secondaryOutcomes measure: Delayed healing, secondaryOutcomes measure: Pigmentation, eligibilityModule sex: ALL, minimumAge: 30 Days, maximumAge: 16 Years, stdAges: CHILD, contactsLocationsModule locations facility: Children's hospital of Nanjing medical university, status: RECRUITING, city: Nanjing, state: Jiangsu, zip: 210008, country: China, contacts name: Tao Han, Dr., role: CONTACT, phone: +86 186 5190 3495, email: dr.hantao@njmu.edu.cn, geoPoint lat: 32.06167, lon: 118.77778, hasResults: False
protocolSection identificationModule nctId: NCT06274996, orgStudyIdInfo id: 2024ZSLYEC-063, briefTitle: Efficacy and Safety Analysis of Upadacitinib in Inflammatory Bowel Disease, statusModule overallStatus: COMPLETED, startDateStruct date: 2021-01-01, primaryCompletionDateStruct date: 2023-12-31, completionDateStruct date: 2023-12-31, studyFirstPostDateStruct date: 2024-02-23, lastUpdatePostDateStruct date: 2024-02-23, sponsorCollaboratorsModule leadSponsor name: Sixth Affiliated Hospital, Sun Yat-sen University, class: OTHER, descriptionModule briefSummary: This study focuses on evaluating Upadacitinib, a new oral medication that inhibits specific enzymes involved in inflammation, for treating inflammatory bowel disease (IBD), which includes conditions such as Crohn\&#39;s Disease and Ulcerative Colitis. The goal is to determine how effective and safe this drug is for patients in China, where data is currently lacking.IBD significantly affects individuals\&#39; quality of life and imposes a high burden on society and healthcare systems. Current treatments don\&#39;t work for everyone, and some patients may need surgery. Upadacitinib has shown promise in other countries for treating IBD and related conditions and has been approved by the US FDA for such use.Our study is retrospective and multicenter, meaning it will look back at patient records from multiple hospitals to analyze the outcomes of those who have received Upadacitinib. Investigators aim to enroll patients treated between January 2020 and December 2023, focusing on adults who have taken Upadacitinib for at least 8 weeks.For patients, families, and healthcare providers, this research could mean a potential new treatment option for IBD. Understanding Upadacitinib\&#39;s efficacy and safety could lead to better management of the disease, possibly reducing the need for surgery and improving the quality of life for those affected by IBD. The ultimate goal is to provide more personalized and effective treatment strategies for IBD patients in China., conditionsModule conditions: Inflammatory Bowel Diseases, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 81, type: ACTUAL, armsInterventionsModule interventions name: Upadacitinib, outcomesModule primaryOutcomes measure: Steroid-Free Clinical Remission, secondaryOutcomes measure: Clinical Response, secondaryOutcomes measure: Endoscopic Remission, secondaryOutcomes measure: Mucosal Healing, secondaryOutcomes measure: Radiological remission, secondaryOutcomes measure: Radiological response, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: the Sixth Affiliated Hospital of Sun Yat-Sen University, city: Guangzhou, state: Guangdong, zip: 510655, country: China, geoPoint lat: 23.11667, lon: 113.25, hasResults: False
protocolSection identificationModule nctId: NCT06274983, orgStudyIdInfo id: SCH-2629, briefTitle: DMD- Interactive Virtual Reality Study, acronym: DMD-IVR, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2023-04-20, primaryCompletionDateStruct date: 2024-02-29, completionDateStruct date: 2024-02-29, studyFirstPostDateStruct date: 2024-02-23, lastUpdatePostDateStruct date: 2024-02-26, sponsorCollaboratorsModule leadSponsor name: Sheffield Children's NHS Foundation Trust, class: OTHER, collaborators name: National Institute for Health Research, United Kingdom, collaborators name: Sheffield Hallam University, collaborators name: UCL Great Ormond Street Institute of Child Health, collaborators name: Leeds General Infirmary, descriptionModule briefSummary: This study will help determine if an Interactive Virtual Reality system can improve the physiotherapy of young patients with Duchenne muscular dystrophy (DMD)., conditionsModule conditions: Duchenne Muscular Dystrophy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 14, type: ACTUAL, armsInterventionsModule interventions name: IVR platform trial, outcomesModule primaryOutcomes measure: Compliance: Ratings of frequency of the DMD-IVR device use for the participant's to complete recommended physiotherapy exercises., primaryOutcomes measure: Compliance: Ratings of duration of the DMD-IVR device use for the participant's to complete recommended physiotherapy exercises., primaryOutcomes measure: Post-trial qualitative interviews on perceptions, acceptability, usability and effectiveness of DMD-IVR device in the context of the family's overall burden of care, primaryOutcomes measure: DMD-IVR Effectiveness standard functional assessments: North Star Ambulatory Assessment (NSAA), primaryOutcomes measure: DMD-IVR effectiveness measures with a Timed test 4 stair climb, primaryOutcomes measure: DMD-IVR effectiveness measured joint range of movement using Goniometer (Standard BASELINE® 12-inch), eligibilityModule sex: ALL, minimumAge: 5 Years, maximumAge: 10 Years, stdAges: CHILD, contactsLocationsModule locations facility: Sheffield Childrens NHS FT, city: Sheffield, state: South Yorkshire, zip: S10 2TH, country: United Kingdom, geoPoint lat: 53.38297, lon: -1.4659, hasResults: False
protocolSection identificationModule nctId: NCT06274957, orgStudyIdInfo id: SaglikBilimleriUN, briefTitle: The Effect of Airway and Chest Wall Oscillation on Respiratory Functions in COPD Patients in Acute Exacerbation, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2024-05-07, completionDateStruct date: 2024-06-01, studyFirstPostDateStruct date: 2024-02-23, lastUpdatePostDateStruct date: 2024-04-17, sponsorCollaboratorsModule leadSponsor name: Saglik Bilimleri Universitesi, class: OTHER, collaborators name: Gulhane Training and Research Hospital, descriptionModule briefSummary: Chronic obstructive pulmonary disease (COPD); It is a common, treatable and preventable disease characterized by progressive and irreversible airflow limitation and has systemic effects with respiratory system involvement. Increased respiratory workload, decreased work ., conditionsModule conditions: COPD Exacerbation Acute, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 27, type: ESTIMATED, armsInterventionsModule interventions name: CONTROL, interventions name: PEP DEVICE, interventions name: HFCWO DEVICE, outcomesModule primaryOutcomes measure: COPD assessment test, primaryOutcomes measure: Clinical COPD Questionnaire, primaryOutcomes measure: mMRC dyspnea scale, primaryOutcomes measure: Richard-Campbell Sleep Questionnaire, primaryOutcomes measure: 30 second sit and stand, primaryOutcomes measure: BODE index, primaryOutcomes measure: chest circumference measurements, primaryOutcomes measure: Modified Borg Scale, primaryOutcomes measure: muscle strenght test, eligibilityModule sex: ALL, minimumAge: 40 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Health Sciences, city: Istanbul, zip: 34353, country: Turkey, contacts name: ZUHAL KUNDURACILAR PROF DR, role: CONTACT, phone: +90 530 219 5286, email: zuhal.kunduracilar@sbu.edu.tr, contacts name: GAMZE KOYUTÜRK PT, PhD(c), role: CONTACT, phone: +90 5065798671, email: gamzealtinkaynak@gmail.com, contacts name: GAMZE KOYUTÜRK PT, PhD (C), role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06274944, orgStudyIdInfo id: PEDS-2023-31694, briefTitle: Nasogastric/Orogastric Tube Placement Confirmation in Neonates Utilizing Self-contained pH Device, a Feasibility Study, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-12, primaryCompletionDateStruct date: 2025-01-31, completionDateStruct date: 2025-01-31, studyFirstPostDateStruct date: 2024-02-23, lastUpdatePostDateStruct date: 2024-03-04, sponsorCollaboratorsModule leadSponsor name: University of Minnesota, class: OTHER, descriptionModule briefSummary: This study is looking at using a self-contained pH device that will assist in confirming placement of a nasogastric or orogastric tube placed in the stomach of hospitalized infants., conditionsModule conditions: Premature Birth, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: nasogastric tube placement pH confirmation device, outcomesModule primaryOutcomes measure: PH reading comparison, eligibilityModule sex: ALL, maximumAge: 2 Years, stdAges: CHILD, contactsLocationsModule locations facility: University of Minnesota, status: RECRUITING, city: Minneapolis, state: Minnesota, zip: 55414, country: United States, contacts name: Brittany Faanes, role: CONTACT, geoPoint lat: 44.97997, lon: -93.26384, hasResults: False
protocolSection identificationModule nctId: NCT06274931, orgStudyIdInfo id: 373, briefTitle: Analysis of the Pulmonary Microbiome, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-01, primaryCompletionDateStruct date: 2024-02-20, completionDateStruct date: 2024-06-20, studyFirstPostDateStruct date: 2024-02-23, lastUpdatePostDateStruct date: 2024-02-23, sponsorCollaboratorsModule leadSponsor name: University Magna Graecia, class: OTHER, descriptionModule briefSummary: The purpose of the protocol is to study the pulmonary microbiome in patients who develop pneumonia., conditionsModule conditions: Pneumonia, conditions: Microbial Colonization, conditions: Microbial Disease, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: PROSPECTIVE, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: Bronchoscopy, outcomesModule primaryOutcomes measure: Assessment of Lung Microbiome in Acute Respiratory Failure, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University Hosp[ital, status: RECRUITING, city: Catanzaro, zip: 88100, country: Italy, contacts name: Andrea Bruni, role: CONTACT, phone: 3401414553, email: andreabruni@unicz.it, geoPoint lat: 38.88247, lon: 16.60086, hasResults: False
protocolSection identificationModule nctId: NCT06274918, orgStudyIdInfo id: 202111418, briefTitle: Reducing ESKAPE Transmission in the Operating Room, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-02-01, primaryCompletionDateStruct date: 2024-06-01, completionDateStruct date: 2024-12-01, studyFirstPostDateStruct date: 2024-02-23, lastUpdatePostDateStruct date: 2024-02-23, sponsorCollaboratorsModule leadSponsor name: University of Iowa, class: OTHER, collaborators name: RDB Bioinformatics, LLC, collaborators name: Georgia-Pacific, descriptionModule briefSummary: This study is designed to examine the impact of a personalized, body worn alcohol dispenser on the epidemiology of ESKAPE transmission in the anesthesia work area for patients undergoing surgery requiring general anesthesia., conditionsModule conditions: Surgical Procedure, Unspecified, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Personalized Body-Worn Alcohol Dispenser, outcomesModule primaryOutcomes measure: ESKAPE transmission events with and without the body worn device, secondaryOutcomes measure: The epidemiology of ESKAPE transmission events, secondaryOutcomes measure: The epidemiology of ESKAPE transmission events, secondaryOutcomes measure: The epidemiology of ESKAPE transmission events, secondaryOutcomes measure: The epidemiology of ESKAPE transmission events, secondaryOutcomes measure: The epidemiology of ESKAPE transmission events, secondaryOutcomes measure: 90-Day Healthcare-Associated Infections, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Iowa, status: RECRUITING, city: Iowa City, state: Iowa, zip: 52242, country: United States, contacts name: Randy W Loftus, MD, role: CONTACT, geoPoint lat: 41.66113, lon: -91.53017, hasResults: False
protocolSection identificationModule nctId: NCT06274905, orgStudyIdInfo id: 160123, briefTitle: Topical Anaesthesia in Cutaneous Head and Neck Surgery, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-02-20, primaryCompletionDateStruct date: 2023-07-07, completionDateStruct date: 2023-07-07, studyFirstPostDateStruct date: 2024-02-23, lastUpdatePostDateStruct date: 2024-02-23, sponsorCollaboratorsModule leadSponsor name: University Hospital Waterford, class: OTHER, descriptionModule briefSummary: This study aims to assess if EMLA or ethyl chloride spray are effective in reducing the pain associated with local anaesthetic administration in cutaneous surgery of the head and neck compared to a placebo and control group through a randomized control trial study design., conditionsModule conditions: Pain, Acute, conditions: Head and Neck Cancer, conditions: Cutaneous Tumor, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: SEQUENTIAL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, maskingDescription: Single blinding (for participants) only for patients receiving EMLA or EMLA placebo., whoMasked: PARTICIPANT, enrollmentInfo count: 124, type: ACTUAL, armsInterventionsModule interventions name: EMLA, interventions name: Ethyl chloride, interventions name: Aqueous cream BP, outcomesModule primaryOutcomes measure: Pain score, secondaryOutcomes measure: Patient satisfaction, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University Hospital Waterford, city: Waterford, zip: X91 ER8E, country: Ireland, geoPoint lat: 52.25833, lon: -7.11194, documentSection largeDocumentModule largeDocs typeAbbrev: Prot_SAP, hasProtocol: True, hasSap: True, hasIcf: False, label: Study Protocol and Statistical Analysis Plan, date: 2022-12-20, uploadDate: 2024-02-06T12:37, filename: Prot_SAP_000.pdf, size: 417714, hasResults: False
protocolSection identificationModule nctId: NCT06274827, orgStudyIdInfo id: GO 22- 881, briefTitle: Electromyographic Analysis of Scapular Muscles During Closed Kinetic Chain Exercises, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-09-25, primaryCompletionDateStruct date: 2023-04-30, completionDateStruct date: 2023-06-20, studyFirstPostDateStruct date: 2024-02-23, lastUpdatePostDateStruct date: 2024-02-26, sponsorCollaboratorsModule leadSponsor name: Hacettepe University, class: OTHER, descriptionModule briefSummary: In shoulder rehabilitation, the inclusion of kinetic chain exercises is advocated in order to provide the necessary energy transfer to produce optimal force with minimal energy consumption. Closed kinetic chain (CKC) exercises are defined as exercises in which the distal segment is stabilized by encountering significant resistance while the proximal segment moves. In contrast, open kinetic chain (OKC) exercises allow the distal segment to move freely without any resistance. Recently, the importance of closed kinetic chain (CKC) exercises has increased in enhancing shoulder joint neuromuscular control by improving dynamic shoulder stability and joint position sense.The most current shoulder rehabilitation protocols include exercises for restoration of scapular muscle imbalances.There exist studies investigating the levels of scapular muscle activation during CKC exercises. Researchers have shown that most CKC exercises especially push-ups and plank variations with the shoulder in the 90° position, generally provide high SA activity and an optimal UT/SA ratio.In the literature, there is limited information on how the level of shoulder elevation affects scapular muscle activity and ratio during closed kinetic chain exercises in the prone position. To effectively prescribe CKC exercises commonly used in rehabilitation and athletic programs, a clear understanding of shoulder elevation changes muscle activity during these exercises is required.Our hypothesis is that glenohumeral joint elevation status will alter scapular muscle activation and activation rates., conditionsModule conditions: Shoulder Pain, conditions: Shoulder Injuries, conditions: Activation, Patient, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, interventionModelDescription: All participants will complete each stage in a randomized order., primaryPurpose: BASIC_SCIENCE, maskingInfo masking: NONE, enrollmentInfo count: 22, type: ACTUAL, armsInterventionsModule interventions name: Superficial Electromyography, outcomesModule primaryOutcomes measure: Muscle activation recorded with surface electromyography (sEMG) during CKC, eligibilityModule sex: MALE, minimumAge: 18 Years, maximumAge: 30 Years, stdAges: ADULT, contactsLocationsModule locations facility: Hacettepe University, city: Ankara, zip: 06430, country: Turkey, geoPoint lat: 39.91987, lon: 32.85427, hasResults: False
protocolSection identificationModule nctId: NCT06274814, orgStudyIdInfo id: AP23.501.038, briefTitle: U/S Guided Rhomboid Intercostal Block Combined With Sub-Serratus Plane Block vs Type 2 Pectoral Nerve Block, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-06-01, primaryCompletionDateStruct date: 2024-04-01, completionDateStruct date: 2024-05-01, studyFirstPostDateStruct date: 2024-02-23, lastUpdatePostDateStruct date: 2024-03-13, sponsorCollaboratorsModule leadSponsor name: National Cancer Institute, Egypt, class: OTHER, descriptionModule briefSummary: The aim of this study is to compare between U/S Guided Rhomboid Intercostal Block Combined with Sub-Serratus Plane Block vs type 2 Pectoral Nerve Block in Analgesia for Breast Cancer Surgery by measuring intraoperative hemodynamics, postoperative pain scores and morphine consumption in the first 24 h postoperative., conditionsModule conditions: Breast Neoplasm Female, conditions: Analgesics, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 69, type: ESTIMATED, armsInterventionsModule interventions name: U/S guided Rhomboid intercostal block (RIB), interventions name: U/S guided RIB combined with the sub-serratus plane block (RISS), outcomesModule primaryOutcomes measure: Total morphine consumption, primaryOutcomes measure: Visual Analog scale score postoperative, secondaryOutcomes measure: Intraoperative fentanyl consumption, secondaryOutcomes measure: Heart rate intraoperative, secondaryOutcomes measure: Timing of first rescue analgesia, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: National cancer Insititute, status: RECRUITING, city: Cairo, zip: 11796, country: Egypt, contacts name: attef, lecturer, role: CONTACT, phone: +20225328286, email: irb@nci.cu.edu.eg, contacts name: ahmed soliman, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 30.06263, lon: 31.24967, hasResults: False
protocolSection identificationModule nctId: NCT06274801, orgStudyIdInfo id: GB002-3102, secondaryIdInfos id: 2023-506334-75, type: EUDRACT_NUMBER, briefTitle: Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT), statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06, primaryCompletionDateStruct date: 2026-12, completionDateStruct date: 2026-12, studyFirstPostDateStruct date: 2024-02-23, lastUpdatePostDateStruct date: 2024-02-23, sponsorCollaboratorsModule leadSponsor name: GB002, Inc., class: INDUSTRY, descriptionModule briefSummary: This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study, conditionsModule conditions: Pulmonary Arterial Hypertension, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 300, type: ESTIMATED, armsInterventionsModule interventions name: Seralutinib, interventions name: Gereic Dry Powder Inhaler, outcomesModule primaryOutcomes measure: Incidence of treatment-emergent adverse events (TEAEs), secondaryOutcomes measure: Changes in distance achieved on the Six-Minute Walk Test (6MWT), secondaryOutcomes measure: Changes in NT-proBNP, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Kansas Medical Center, city: Kansas City, state: Kansas, zip: 66160, country: United States, geoPoint lat: 39.11417, lon: -94.62746, locations facility: Pulmonary Associates of Richmond, Inc., city: Richmond, state: Virginia, zip: 23230, country: United States, geoPoint lat: 37.55376, lon: -77.46026, hasResults: False